Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-03-11 @ 3:41 AM
Study NCT ID:
NCT01609933
Status:
COMPLETED
Last Update Posted:
2018-06-19
First Post:
2012-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-30
First Submit QC Date:
None
Study First Post Date:
2012-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-28
Results First Submit QC Date:
None
Results First Post Date:
2018-06-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-21
Last Update Post Date:
2018-06-19
Last Update Post Date Type:
ACTUAL